National Institute of Parasitic Diseases, China : 70 years and beyond /
Saved in:
| Imprint: | London : Academic Press, 2020. |
|---|---|
| Description: | 1 online resource |
| Language: | English |
| Series: | Advances in parasitology ; v. 110 Advances in parasitology ; v. 110. |
| Subject: | |
| Format: | E-Resource Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/12380125 |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | 12380125 | ||
| 005 | 20200828230031.5 | ||
| 006 | m o d | ||
| 007 | cr |n||||||||| | ||
| 008 | 200622s2020 enk o 000 0 eng d | ||
| 020 | |a 9780128207536 |q (electronic bk.) | ||
| 020 | |a 0128207531 |q (electronic bk.) | ||
| 020 | |z 0128207523 | ||
| 020 | |z 9780128207529 | ||
| 035 | |a (OCoLC)1159209208 | ||
| 035 | 9 | |a (OCLCCM-CC)1159209208 | |
| 040 | |a YDX |b eng |c YDX |d OPELS |d EBLCP |d OCLCF |d OCLCA | ||
| 043 | |a a-cc--- | ||
| 049 | |a MAIN | ||
| 050 | 4 | |a RC119 | |
| 245 | 0 | 0 | |a National Institute of Parasitic Diseases, China : |b 70 years and beyond / |c edited by Dirk Engels, Yu Wang, Xiao-Nong Zhou. |
| 260 | |a London : |b Academic Press, |c 2020. | ||
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent |0 http://id.loc.gov/vocabulary/contentTypes/txt | ||
| 337 | |a computer |b c |2 rdamedia |0 http://id.loc.gov/vocabulary/mediaTypes/c | ||
| 338 | |a online resource |b cr |2 rdacarrier |0 http://id.loc.gov/vocabulary/carriers/cr | ||
| 490 | 1 | |a Advances in parasitology ; |v v. 110 | |
| 505 | 0 | |a Intro -- National Institute of Parasitic Diseases, China: 70 Years and Beyond -- Copyright -- Contents -- Contributors -- Preface: Development strategy of NIPD-CTDR in the new era -- 1. Foreword -- 2. Major achievements -- 2.1. Promoting parasitic diseases from control to elimination -- 2.2. Promoting technological innovation in national medical parasitology -- 2.3. Promoting the disciplinary development in tropical medicine and global health -- 3. Future orientations -- References -- Chapter One: Contributions and achievements on schistosomiasis control and elimination in China by NIPD-CTDR | |
| 505 | 8 | |a 1. Introduction -- 2. The endemic status of schistosomiasis in P.R. China -- 3. Transmission patterns and evolution of the control strategy on schistosomiasis -- 3.1. Epidemiological patterns -- 3.1.1. Plains & water network regions -- 3.1.2. Marshlands & lakes regions -- 3.1.2.1. Combination of sluice construction and snail control in the Poyang Lake -- 3.1.2.2. Test for snail control by aircraft spraying -- 3.1.3. Hilly & mountainous regions -- 3.1.4. The influence of Three Gorges Dam on schistosomiasis transmission -- 3.2. Strategy evolution | |
| 505 | 8 | |a 3.2.1. The first stage, from the mid-1950s to the early 1980s -- 3.2.2. The second stage, from the 1980s to the beginning of the 21st century -- 3.2.3. The third stage, from 2004 to present -- 4. Diagnostics and vaccine development -- 4.1. Development and application of diagnostics -- 4.1.1. Parasitological diagnosis -- 4.1.1.1. Hatching test -- 4.1.1.2. Improved Kato-Katz method combined with faecal hatching evaluation -- 4.1.2. Immunological diagnosis -- 4.1.2.1. The intradermal test -- 4.1.2.2. Cercarien-Hullen-Reaktion -- 4.1.2.3. The circumoval precipitin test | |
| 505 | 8 | |a 4.1.2.4. Latex agglutination test -- 4.1.2.5. Enzyme-linked immunoelectron transfer blot assay -- 4.1.2.6. Enzyme-linked immunosorbent assay -- 4.1.2.7. Rapid diagnostic kits -- 4.1.3. Assessment of diagnostic assays and quality control -- 4.1.3.1. Assessment of diagnostic assays -- 4.1.3.2. Quality control -- 4.2. Vaccines development -- 4.2.1. Vaccine candidate antigens -- 4.2.2. Multivalent vaccines -- 4.2.3. Immunization test on cattle -- 5. Research and development of drugs and molluscicides -- 5.1. Drug development for human treatment -- 5.1.1. Praziquantel | |
| 505 | 8 | |a 5.1.1.1. Effect of praziquantel on the nervous system activity of schistosomes -- 5.1.1.2. Effect of praziquantel on the metabolism of schistosomes -- 5.1.1.3. Effect of praziquantel on the ultrastructure of different stages of schistosomes -- 5.1.1.4. Comparison of the effects of different structures of praziquantel on schistosomes -- 5.1.2. Artemether -- 5.1.2.1. Mechanism of action -- 5.1.2.2. Field trials -- 5.1.3. Other new anti-schistosomiasis drugs -- 5.2. Molluscicides development -- 5.2.1. Bromoacetamide -- 5.2.2. Niclosamide -- 5.2.3. Development of novel chemical molluscicides | |
| 610 | 2 | 0 | |a National Institute of Parasitic Diseases. |
| 610 | 2 | 0 | |a Zhongguo ji bing yu fang kong zhi zhong xin. |0 http://id.loc.gov/authorities/names/n2005090706 |
| 650 | 0 | |a Parasitic diseases |z China. | |
| 650 | 0 | |a Parasitic diseases |x Research |z China. | |
| 650 | 7 | |a Parasitic diseases. |2 fast |0 (OCoLC)fst01053151 | |
| 650 | 7 | |a Parasitic diseases |x Research. |2 fast |0 (OCoLC)fst01053163 | |
| 651 | 7 | |a China. |2 fast |0 (OCoLC)fst01206073 | |
| 655 | 0 | |a Electronic books. | |
| 655 | 4 | |a Electronic books. | |
| 700 | 1 | |a Engels, Dirk. |0 http://id.loc.gov/authorities/names/n2016182059 |1 http://viaf.org/viaf/241145857985023021615 | |
| 700 | 1 | |a Wang, Yu. |0 http://id.loc.gov/authorities/names/n83002709 |1 http://viaf.org/viaf/63889773 | |
| 700 | 1 | |a Zhou, Xiao-nong. |0 http://id.loc.gov/authorities/names/n2010181048 |1 http://viaf.org/viaf/107974740 | |
| 776 | 0 | 8 | |c Original |z 0128207523 |z 9780128207529 |w (OCoLC)1135665437 |
| 830 | 0 | |a Advances in parasitology ; |v v. 110. |0 http://id.loc.gov/authorities/names/no2009090544 | |
| 903 | |a HeVa | ||
| 929 | |a oclccm | ||
| 999 | f | f | |i 522315c8-e549-57ae-bf09-8240f3b5e07d |s 08c8a28e-8285-5ea8-a3de-b7bf4cee13c1 |
| 928 | |t Library of Congress classification |a RC119 |l Online |c UC-FullText |u https://www.sciencedirect.com/science/bookseries/0065308X/110 |z Elsevier |g ebooks |i 11980226 | ||